V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280008605 | 280009051 | 1.57 | null | Curative (C) | 2017-05-18 | 2017-11-27 | Cetuximab +Cisplatin + FU (Cycle 1) | 02 | N | 280028184 | CETUXIMAB + CISPLATIN + FU |
| 280008606 | 280005822 | 1.71 | 140 | Palliative (P) | 2017-09-25 | 2017-09-28 | VAI (Ifos 3g/m2) | N | N | 280028184 | VAI |
| 280008607 | 280005823 | 1.53 | 81.6 | Palliative (P) | 2017-11-07 | 2017-11-07 | Etoposide + Ifosfamide (5 days) | N | N | 280028199 | ETOPOSIDE + IFOSFAMIDE |
| 280008608 | 280005824 | 1.74 | 73.2 | Neo-adjuvant (N) | 2016-10-27 | 2017-01-27 | Etoposide + Ifosfamide (5 days) | 2 | N | 280028205 | ETOPOSIDE + IFOSFAMIDE |
| 280008609 | 280005826 | 1.6 | 46.6 | Adjuvant (A) | 2015-05-19 | 2015-05-19 | ETOPOSIDE + IFOSFAMIDE | 02 | N | 280028205 | ETOPOSIDE + IFOSFAMIDE |
| 280008610 | 280005827 | 1.68 | 60.4 | Palliative (P) | 2015-10-07 | 2015-10-07 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280028211 | CISPLATIN + FLUOROURACIL |
| 280008611 | 280005828 | 0 | 80.1 | Curative (C) | null | 2018-08-27 | Cisplatin +Fluorouracil (3 wk) | N | N | 280028214 | CISPLATIN + FLUOROURACIL |
| 280008612 | 280005830 | null | 57.9 | Curative (C) | 2017-04-09 | 2017-04-09 | Doxorubicin + Ifosfamide | 02 | N | 280028214 | DOXORUBICIN + IFOSFAMIDE |
| 280008613 | 280005831 | null | 57.8 | Adjuvant (A) | 2017-02-06 | 2017-02-27 | CYCLOPHOSPHAMIDE | N | N | 280028218 | CYCLOPHOSPHAMIDE |
| 280008614 | 280005832 | 1.47 | 86 | Adjuvant (A) | 2016-04-22 | 2016-11-26 | Etoposide + Ifosfamide (5 days) | 02 | N | 280028223 | ETOPOSIDE + IFOSFAMIDE |
| 280008615 | 280010603 | 0 | 89 | Palliative (P) | 2013-02-17 | 2013-03-05 | Doxorubicin + Olaratumab | N | N | 280028224 | DOXORUBICIN + OLARATUMAB |
| 280008616 | 280010603 | 1.7 | 36.1 | Curative (C) | 2014-08-06 | 2014-08-16 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | Y | 280028224 | GEMCITABINE |
| 280008617 | 280005833 | 1.7 | 79 | Palliative (P) | 2017-06-17 | 2017-12-28 | Etoposide + Ifosfamide (3 days) | N | N | 280028233 | ETOPOSIDE + IFOSFAMIDE |
| 280008618 | 280005833 | 1.79 | 82.9 | Curative (C) | 2018-06-07 | 2018-06-27 | EW EuroEwing 2012 Arm A VIDE | N | N | 280028233 | EURO-EWING |
| 280008619 | 280005833 | 1.62 | null | Curative (C) | 2014-02-07 | 2014-02-07 | Oxaliplatin + Modified de Gramont | N | N | 280028233 | OXALIPLATIN + MDG |
| 280008620 | 280009059 | 1.72 | null | null | 2016-06-15 | 2016-10-29 | VAI (Ifos 3g/m2) | 02 | N | 280028242 | IRINOTECAN + TEMOZOLOMIDE |
| 280008621 | 280005836 | 1.61 | 100.2 | Curative (C) | 2017-08-12 | 2017-08-15 | CISPLATIN + GEMCITABINE | N | N | 280028243 | CISPLATIN + GEMCITABINE |
| 280008622 | 280005837 | 1.67 | 63 | Curative (C) | null | 2019-04-28 | CETUXIMAB + CISPLATIN + FU | N | N | 280028248 | CETUXIMAB + CISPLATIN + FU |
| 280008623 | 280005837 | 1.72 | 86.4 | Curative (C) | 2013-11-29 | 2013-12-06 | Etoposide + Ifosfamide (3 days) | null | Y | 280028248 | ETOPOSIDE + IFOSFAMIDE |
| 280008624 | 280005839 | 1.74 | 70.4 | Palliative (P) | 2015-06-21 | 2015-08-06 | EW EuroEwing 99 : VActI | 02 | Y | 280028256 | EURO-EWING |
| 280008625 | 280005840 | 1.7 | 90.8 | Curative (C) | 2014-02-06 | 2014-02-19 | VAC | 2 | N | 280028259 | CAV |
| 280008626 | 280005844 | 1.6 | 57.8 | Curative (C) | 2017-03-24 | 2017-03-31 | CARBOPLATIN + PACLITAXEL | N | N | 280028261 | CARBOPLATIN + PACLITAXEL |
| 280008627 | 280005844 | 1.78 | 61.1 | Adjuvant (A) | 2017-05-24 | 2017-05-31 | VAC | 2 | null | 280028261 | CAV |
| 280008628 | 280005845 | 1.77 | 95.3 | Neo-adjuvant (N) | 2017-09-30 | 2017-10-04 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 280028271 | CETUXIMAB + CISPLATIN + FU |
| 280008629 | 280010607 | 1.79 | 75.6 | Adjuvant (A) | 2013-03-08 | 2013-04-11 | EW EuroEwing 99 : VIDE | N | Y | 280028273 | EURO-EWING |
| 280008630 | 280005846 | 1.73 | 64.3 | Neo-adjuvant (N) | null | 2016-07-11 | VAC | 2 | null | 280028275 | CAV |
| 280008631 | 280005849 | 1.61 | 93.4 | Palliative (P) | 2013-05-01 | 2013-06-19 | CAV | 2 | N | 280028276 | CAV |
| 280008632 | 280009067 | null | 70.6 | Curative (C) | 2017-02-25 | 2017-03-15 | Carboplatin + Etoposide iv&po | null | null | 280028277 | CARBOPLATIN + ETOPOSIDE |
| 280008633 | 280005852 | 1.74 | 77 | Adjuvant (A) | 2014-12-16 | 2014-12-16 | Irinotecan + Modified De Gramont | N | N | 280028277 | VAI |
| 280008634 | 280005853 | 1.61 | 53.8 | Palliative (P) | 2015-07-09 | 2015-08-05 | Etoposide + Ifosfamide (5 days) | N | null | 280028292 | ETOPOSIDE + IFOSFAMIDE |
| 280008635 | 280010609 | 1.71 | 65.5 | Disease modification (D) | 2016-03-23 | 2016-04-23 | VAC | null | null | 280028299 | CAV |
| 280008636 | 280005856 | 1.79 | 105.25 | Adjuvant (A) | 2014-06-07 | 2014-06-15 | CISPLATIN + GEMCITABINE | N | N | 280028300 | CISPLATIN + GEMCITABINE |
| 280008637 | 280005858 | 1.77 | 75.7 | Curative (C) | 2013-08-19 | 2013-09-23 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 280028302 | GEMCITABINE |
| 280008638 | 280005864 | 1.66 | 81 | null | 2015-03-29 | 2015-05-11 | ETOPOSIDE + IFOSFAMIDE | 02 | N | 280028305 | ETOPOSIDE + IFOSFAMIDE |
| 280008639 | 280005866 | 1.73 | 73.3 | Palliative (P) | 2018-05-10 | 2018-05-17 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280028320 | CISPLATIN + FLUOROURACIL |
| 280008640 | 280005867 | 1.75 | 104 | Curative (C) | 2014-08-28 | 2014-09-18 | Oxaliplatin + Modified de Gramont | N | N | 280028322 | OXALIPLATIN + MDG |
| 280008641 | 280009077 | 1.63 | 82.2 | Curative (C) | 2013-11-01 | 2013-11-08 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 280028326 | GEMCITABINE |
| 280008642 | 280005870 | 1.8 | 86.8 | Neo-adjuvant (N) | 2017-12-18 | 2018-02-17 | Carboplatin + Etoposide IV 3 day | N | N | 280028326 | CARBOPLATIN + ETOPOSIDE |
| 280008643 | 280005872 | null | 58.5 | Palliative (P) | 2016-10-08 | 2016-10-15 | CARBOPLATIN + ETOPOSIDE | N | N | 280028330 | CARBOPLATIN + ETOPOSIDE |
| 280008644 | 280005873 | 1.7 | 65 | Curative (C) | 2015-11-06 | 2015-11-07 | Carboplatin + Etoposide iv&po | N | N | 280028330 | CARBOPLATIN + ETOPOSIDE |
| 280008645 | 280005874 | 1.71 | null | Neo-adjuvant (N) | null | 2016-06-10 | Gemcitabine 1000mg/m2 D1 8 15 | N | null | 280028334 | GEMCITABINE |
| 280008646 | 280010616 | null | null | null | 2017-01-18 | 2017-03-07 | Cetuximab+Cisplatin+FU (> Cycle 2) | Y | null | 280028335 | CETUXIMAB + CISPLATIN + FU |
| 280008647 | 280009082 | 1.7 | null | Disease modification (D) | 2015-10-11 | 2015-11-16 | DE-ESCALATE TRIAL | N | Y | 280028345 | DE-ESCALATE TRIAL |
| 280008648 | 280005876 | 1.64 | 59.8 | Curative (C) | 2013-02-07 | 2013-02-07 | VAC | N | Y | 280028348 | CAV |
| 280008649 | 280005877 | 1.73 | 91.7 | Curative (C) | 2016-12-14 | 2016-12-17 | Cetuximab +Cisplatin + FU (Cycle 1) | 02 | Y | 280028349 | CETUXIMAB + CISPLATIN + FU |
| 280008650 | 280005878 | 1.66 | 72.4 | Palliative (P) | 2017-03-22 | 2017-04-19 | Doxorubicin + Ifosfamide | N | N | 280028353 | DOXORUBICIN + IFOSFAMIDE |
| 280008651 | 280005880 | 1.6 | null | Palliative (P) | 2015-12-27 | 2016-01-25 | EW EuroEwing 99 : VActI | Y | N | 280028353 | EURO-EWING |
| 280008652 | 280005880 | 1.63 | 90.3 | Palliative (P) | 2018-05-25 | 2018-06-16 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 280028353 | GEMCITABINE |
| 280008654 | 280005882 | 1.82 | 92.2 | Curative (C) | 2018-05-30 | 2018-06-19 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | null | 280028363 | GEMCITABINE |
| 280008655 | 280005883 | 1.72 | 62.45 | Adjuvant (A) | null | 2013-12-22 | DE-ESCALATE TRIAL | null | null | 280028365 | DE-ESCALATE TRIAL |